Completed first close of pre-series A fundraising of 460 million yen
We are pleased to announce that we have raised 460 million yen in the first close of our pre-series A round.
In this round, we raised a total of 460 million yen with existing investors Chiiki to Hito to Mirai Co., Ltd. (CJS2), GxPartners LLP, and mint, as well as new investors Nissay Capital Co., Ltd., Sumitomo Corporation, and 77 Capital Co., Ltd. as underwriters. With this first close, our total funding has now reached 580 million yen.
Background to fundraising and use of funds raised
The funds raised this time will be used for business and product development, as well as to strengthen the organizational foundation for future business expansion both domestically and overseas.
AiRato’s Future
AiRato aims to maximize the potential of radiation therapy through radiation therapy x AI, further popularize excellent radiation therapy that is minimally invasive and completely painless, and realize the big dream of saving all cancer patients with radiation therapy.
News
日経新聞
https://www.nikkei.com/article/DGXZQOCC2426L0U5A620C2000000
河北新報
https://kahoku.news/articles/20250624khn000048.html